Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Symptom Cluster

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Symptom Cluster in 5 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research Excerpts

ExcerptRelevanceReference
"Dextromethorphan, a noncompetitive blocker of the N-methyl-D-aspartate (NMDA) type of glutamate receptor, at 45, 60 and 75 mg/kg, ip doses induced a behavioural syndrome characterised by reciprocal forepaw treading, lateral head-weaving, hind-limb abduction and flat body posture."7.73Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. ( Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM, 2005)
"Catalepsy was measured in rats using both the cross-legged position test and the bar test."5.31Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. ( Colpaert, FC; Kleven, MS; Koek, W; Prinssen, EP, 2000)
"Dextromethorphan, a noncompetitive blocker of the N-methyl-D-aspartate (NMDA) type of glutamate receptor, at 45, 60 and 75 mg/kg, ip doses induced a behavioural syndrome characterised by reciprocal forepaw treading, lateral head-weaving, hind-limb abduction and flat body posture."3.73Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. ( Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM, 2005)
" Dose-response curves created with 8-OH DPAT for the serotonin behavioral syndrome were similar in bile duct-resected and sham-operated rats."1.33Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat. ( Bozdayi, AM; Bozkaya, H; Celik, T; Cinar, K; Gören, MZ; Gürdal, H; Onder, FO; Tan, A; Terzioğlu, B; Uzunalimoğlu, O; Yurdaydin, C, 2005)
"Catalepsy was measured in rats using both the cross-legged position test and the bar test."1.31Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. ( Colpaert, FC; Kleven, MS; Koek, W; Prinssen, EP, 2000)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Celik, T1
Gören, MZ1
Cinar, K1
Gürdal, H1
Onder, FO1
Tan, A1
Terzioğlu, B1
Bozdayi, AM1
Bozkaya, H1
Uzunalimoğlu, O1
Yurdaydin, C1
Gaikwad, RV1
Gaonkar, RK1
Jadhav, SA1
Thorat, VM1
Jadhav, JH1
Balsara, JJ1
Blanchard, RJ1
Griebel, G1
Guardiola-Lemaître, B1
Brush, MM1
Lee, J1
Blanchard, DC1
Prinssen, EP1
Koek, W1
Colpaert, FC1
Kleven, MS1
Yamada, J1
Sugimoto, Y1
Horisaka, K1

Other Studies

5 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Symptom Cluster

ArticleYear
Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat.
    Hepatology (Baltimore, Md.), 2005, Volume: 41, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain; Cholestasis; Dose-Response

2005
Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats.
    Indian journal of experimental biology, 2005, Volume: 43, Issue:7

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antitussive Agents; Behavior, Animal; Buspirone; Ce

2005
An ethopharmacological analysis of selective activation of 5-HT1A receptors: the mouse 5-HT1A syndrome.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 57, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Feeding Behavior; Grooming; Male;

1997
Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
    Behavioural pharmacology, 2000, Volume: 11, Issue:3-4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Behav

2000
The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    European journal of pharmacology, 1988, Sep-23, Volume: 154, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Dopamine Antagonists; Male; Mice;

1988